HealthEquity, Inc. (HQY) - What Are Investment Firms Saying About This Stock?

Key Points

• Analyst sentiment is broadly positive: HealthEquity has a “Moderate Buy” consensus among 13 analysts, with 11 buy ratings, one strong buy, and one sell. The average 12-month price target is $113.53.
• Latest reported quarterly results beat estimates: EPS was $1.24 versus the $1.19 consensus, and revenue of $350.73 million slightly exceeded expectations and grew 95.5% year over year.
• Shares opened at $103.54, within a 52-week range of $72.76–$110.26. Director Adrian Dillon sold 7,632 shares under a pre-arranged trading plan, while institutional investors and hedge funds hold 99.55% of the stock.

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the thirteen ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $113.53.

A number of analysts have commented on HQY shares. Deutsche Bank Aktiengesellschaft raised their price objective on HealthEquity from $135.00 to $142.00 and gave the stock a "buy" rating in a research report on Monday, August 31st. Weiss Ratings upgraded HealthEquity from a "buy (b-)" rating to a "buy (b)" rating in a research note on Monday, November 2nd. Telsey Advisory Group set a $111.00 target price on HealthEquity in a research note on Friday, August 28th. BTIG Research reaffirmed a "buy" rating and issued a $115.00 target price on shares of HealthEquity in a research report on Friday, August 28th. Finally, Raymond James Financial reiterated a "strong-buy" rating on shares of HealthEquity in a research note on Thursday, September 3rd.

HealthEquity Stock Performance

Shares of HQY opened at $103.54 on Wednesday. The company has a 50-day moving average of $95.78 and a two-hundred day moving average of $89.69. The stock has a market cap of $8.56 billion, a price-to-earnings ratio of 37.38, a PEG ratio of 1.61 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. HealthEquity has a one year low of $72.76 and a one year high of $110.26.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. The company had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company's revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities research analysts expect that HealthEquity will post 3.94 earnings per share for the current year.

Insider Activity

In other news, Director Adrian Dillon sold 7,632 shares of the firm's stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company's stock, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.60% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Signaturefd LLC boosted its stake in HealthEquity by 11.7% in the 3rd quarter. Signaturefd LLC now owns 1,359 shares of the company's stock valued at $120,000 after buying an additional 142 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of HealthEquity by 12.0% in the third quarter. GAMMA Investing LLC now owns 1,479 shares of the company's stock valued at $131,000 after buying an additional 158 shares in the last quarter. State of Wyoming raised its stake in shares of HealthEquity by 4.3% in the third quarter. State of Wyoming now owns 4,350 shares of the company's stock worth $385,000 after acquiring an additional 181 shares during the last quarter. Fifth Third Bancorp boosted its position in HealthEquity by 0.8% in the 3rd quarter. Fifth Third Bancorp now owns 23,363 shares of the company's stock valued at $2,067,000 after buying an additional 190 shares during the last quarter. Finally, Cim Investment Management Inc. increased its position in HealthEquity by 5.0% in the second quarter. Cim Investment Management Inc. now owns 4,007 shares of the company's stock worth $362,000 after purchasing an additional 191 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.